Sale

Topical Pain Relief Market

Global Topical Pain Relief Market Size, Growth, Forecast: By Class: Opioids, Non-Opioids; By Product Type: Over-The-Counter, Prescription; By Formulation: Ointment, Gel, Spray, Patch, Others; By Distribution Channel: Pharmacies and Drug Stores, Retail and Grocery Stores, Online, Others; Regional Analysis; Supplier Landscape; 2024-2032

Global Topical Pain Relief Market Outlook

The global topical pain relief market size attained a value of about USD 10.61 billion in 2023, driven by rising prevalence of arthritis and other bone-related diseases, rising pharmaceutical industry, and growing geriatric population. The market is further expected to grow at a CAGR of 5% during the forecast period of 2024-2032 to reach nearly USD 16.45 billion by 2032.

 

Global Topical Pain Relief Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Increasing Demand for Non-Opioids to Augment the Topical Pain Relief Industry Growth

Based on class, the non-opioids segment accounts for a significant share in the topical pain relief industry and is expected to grow rapidly over the forecast period due to the increased preference for non-opioids over opioid drugs to treat mild to moderate pain. Non-opioids are often used to treat acute or persistent pain because they have fewer side effects as compared to opioids and do not cause addiction. While non-opioid drugs are particularly suitable for pain in musculoskeletal conditions, opioid analgesics are considered more suitable for treating moderate to severe pain, especially of visceral origin. The growth of this segment is primarily driven by the increasing awareness pertaining to the negative effects of long-term opioid therapy, which may adversely affect pain sensitivity, widespread concerns about opioid misuse and iatrogenic addiction, and an increase in the prevalence of arthritis and other joint problems.

 

North America to Provide Enhanced Growth Opportunities to the Topical Pain Relief Industry

Region-wise, North America accounts for a significant market share and is expected to witness a robust growth over the forecast period. This is due to the region's early legalisation of topical pain relievers and high acceptance of over-the-counter pain relievers. Moreover, due to the presence of some of the leading industry players in the region, the market is expected to grow in the forecast period.

 

Topical Pain Relief: Market Segmentation

Muscle pains, sprains, and strains are treated with topical painkillers. They can also help in providing relief from painful arthritis. Since topical analgesics have fewer side effects than oral painkillers, they are often prescribed instead of oral painkillers.

 

Global Topical Pain Relief Market by Segment

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

By class, the market is divided into:

  • Opioids
  • Non-Opioids

Based on product type, the industry can be segmented into:

  • Over-the-Counter
  • Prescription

The market is divided based on formulation into:

  • Ointment
  • Gel
  • Spray
  • Patch
  • Others

On the basis of distribution channel, the industry can be categorised into:

  • Pharmacies and Drug Stores
  • Retail and Grocery Stores
  • Online
  • Others

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Global Topical Pain Relief Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Increasing Prevalence of Arthritis and Other Bone-Related Diseases to Bolster the Growth of the Topical Pain Relief Industry

The increasing prevalence of arthritis and other bone-related diseases, as well as diabetic neuropathy, which causes pain, is driving the growth of the global topical pain relief industry. Other factors driving the market growth include an increased adoption of topical pain-relieving drugs, which have less side effects than oral pain relievers, the growing global geriatric population, and an increase in demand for topical pain relievers among athletes. Further, the expansion of online retail channels for topical therapeutics is expected to provide the industry with lucrative growth opportunities.

Over the forecast period, the increase in the number of patients undergoing prolonged treatment for diseases, such as skin cancer, is expected to drive the growth of the market.

 

Key Industry Players in the Global Topical Pain Relief Market

The report gives a detailed analysis of the following key players in the global topical pain relief market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Sanofi SA
  • Novartis AG 
  • GlaxoSmithKline Plc. 
  • Reckitt Benckiser Group Plc. 
  • Johnson & Johnson Consumer Inc.
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

 

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Class
  • Product Type
  • Formulation
  • Distribution Channel
  • Region
Breakup by Class
  • Opioids
  • Non-Opioids
Breakup by Product Type
  • Over-The-Counter
  • Prescription
Breakup by Formulation
  • Ointment
  • Gel
  • Spray
  • Patch
  • Others
Breakup by Distribution Channel
  • Pharmacies and Drug Stores
  • Retail and Grocery Stores
  • Online
  • Others
Breakup by Regions
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • Sanofi SA
  • Novartis AG
  • GlaxoSmithKline Plc
  • Reckitt Benckiser Group Plc.
  • Johnson & Johnson Consumer Inc.
  • AdvaCare Pharma
  • Topical Biomedics, Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Nestle S.A.
  • Pfizer Inc.
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.

1    Preface
    1.1    Objectives of the Study
    1.2    Key Assumptions 
    1.3    Report Coverage – Key Segmentation and Scope  
    1.4    Research Methodology
2    Executive Summary
3    Global Topical Pain Relief Market Overview 

    3.1    Global Topical Pain Relief Market Historical Value (2017-2023) 
    3.2    Global Topical Pain Relief Market Forecast Value (2024-2032)
4    Global Topical Pain Relief Market Landscape
    4.1    Global Topical Pain Relief Developers Landscape
        4.1.1    Analysis by Year of Establishment
        4.1.2    Analysis by Company Size
        4.1.3    Analysis by Region
    4.2    Global Topical Pain Relief Product Landscape
        4.2.1    Analysis by Class
        4.2.2    Analysis by Product Type
        4.2.3    Analysis by Formulation
        4.2.4    Analysis by Distribution Channel
5    Global Topical Pain Relief Market Dynamics
    5.1    Market Drivers and Constraints
    5.2    SWOT Analysis
    5.3    Porter’s Five Forces Model 
    5.4    Key Demand Indicators
    5.5    Key Price Indicators
    5.6    Industry Events, Initiatives, and Trends 
    5.7    Value Chain Analysis
6    Global Topical Pain Relief Market Segmentation 
    6.1    Global Topical Pain Relief Market by Class
        6.1.1    Market Overview
        6.1.2    Opioids
        6.1.3    Non-Opioids
    6.2    Global Topical Pain Relief Market by Product Type
        6.2.1    Market Overview
        6.2.2    Over-The-Counter
        6.2.3    Prescription
    6.3    Global Topical Pain Relief Market by Formulation
        6.3.1    Market Overview
        6.3.2    Ointment
        6.3.3    Gel
        6.3.4    Spray
        6.3.5    Patch
        6.3.6    Others
    6.4    Global Topical Pain Relief Market by Distribution Channel
        6.4.1    Market Overview
        6.4.2    Pharmacies and Drug Stores
        6.4.3    Retail and Grocery Stores
        6.4.4    Online
        6.4.5    Others
    6.5    Global Topical Pain Relief Market by Region
        6.5.1    Market Overview
        6.5.2    North America 
        6.5.3    Europe
        6.5.4    Asia Pacific
        6.5.5    Latin America
        6.5.6    Middle East and Africa
7    North America Topical Pain Relief Market
    7.1    Market Share by Country
    7.2    United States of America
    7.3    Canada
8    Europe Topical Pain Relief Market
    8.1    Market Share by Country
    8.2    United Kingdom
    8.3    Germany
    8.4    France
    8.5    Italy
    8.6    Others
9    Asia Pacific Topical Pain Relief Market
    9.1    Market Share by Country
    9.2    China
    9.3    Japan
    9.4    India
    9.5    ASEAN
    9.6    Australia
    9.7    Others
10    Latin America Topical Pain Relief Market
    10.1    Market Share by Country
    10.2    Brazil
    10.3    Argentina
    10.4    Mexico
    10.5    Others
11    Middle East and Africa Topical Pain Relief Market
    11.1    Market Share by Country
    11.2    Saudi Arabia
    11.3    United Arab Emirates
    11.4    Nigeria
    11.5    South Africa
    11.6    Others
12    Patent Analysis
    12.1    Analysis by Type of Patent
    12.2    Analysis by Publication year
    12.3    Analysis by Issuing Authority
    12.4    Analysis by Patent Age
    12.5    Analysis by CPC Analysis
    12.6    Analysis by Patent Valuation 
    12.7    Analysis by Key Players
13    Grants Analysis
    13.1    Analysis by year
    13.2    Analysis by Amount Awarded
    13.3    Analysis by Issuing Authority
    13.4    Analysis by Grant Application
    13.5    Analysis by Funding Institute
    13.6    Analysis by NIH Departments
    13.7    Analysis by Recipient Organization 
14    Funding Analysis
    14.1    Analysis by Funding Instances
    14.2    Analysis by Type of Funding
    14.3    Analysis by Funding Amount
    14.4    Analysis by Leading Players
    14.5    Analysis by Leading Investors
    14.6    Analysis by Geography
15    Partnership and Collaborations Analysis
    15.1    Analysis by Partnership Instances
    15.2    Analysis by Type of Partnership
    15.3    Analysis by Leading Players
    15.4    Analysis by Geography
16    Regulatory Framework
    16.1    Regulatory Overview
        16.1.1    US FDA
        16.1.2    EU EMA
        16.1.3    INDIA CDSCO
        16.1.4    JAPAN PMDA
        16.1.5    Others
17    Supplier Landscape
    17.1    Sanofi SA
        17.1.1    Financial Analysis
        17.1.2    Product Portfolio
        17.1.3    Demographic Reach and Achievements
        17.1.4    Mergers and Acquisitions
        17.1.5    Certifications
    17.2    Novartis AG
        17.2.1    Financial Analysis
        17.2.2    Product Portfolio
        17.2.3    Demographic Reach and Achievements
        17.2.4    Mergers and Acquisitions
        17.2.5    Certifications
    17.3    GlaxoSmithKline Plc
        17.3.1    Financial Analysis
        17.3.2    Product Portfolio
        17.3.3    Demographic Reach and Achievements
        17.3.4    Mergers and Acquisitions
        17.3.5    Certifications
    17.4    Reckitt Benckiser Group Plc.
        17.4.1    Financial Analysis
        17.4.2    Financial Portfolio
        17.4.3    Demographic Reach and Achievements
        17.4.4    Mergers and Acquisitions
        17.4.5    Certifications
    17.5    Johnson & Johnson Consumer Inc.
        17.5.1    Financial Analysis
        17.5.2    Product Portfolio
        17.5.3    Demographic Reach and Achievements
        17.5.4    Mergers and Acquisitions
        17.5.5    Certifications
    17.6    AdvaCare Pharma
        17.6.1    Financial Analysis
        17.6.2    Product Portfolio
        17.6.3    Demographic Reach and Achievements
        17.6.4    Mergers and Acquisitions
        17.6.5    Certifications
    17.7    Topical Biomedics, Inc.
        17.7.1    Financial Analysis
        17.7.2    Product Portfolio
        17.7.3    Demographic Reach and Achievements
        17.7.4    Mergers and Acquisitions
        17.7.5    Certifications
    17.8    Sun Pharmaceutical Industries Ltd.
        17.8.1    Financial Analysis
        17.8.2    Product Portfolio
        17.8.3    Demographic Reach and Achievements
        17.8.4    Mergers and Acquisitions
        17.8.5    Certifications
    17.9    Nestle S.A.
        17.9.1    Financial Analysis
        17.9.2    Product Portfolio
        17.9.3    Demographic Reach and Achievements
        17.9.4    Mergers and Acquisitions
        17.9.5    Certifications
    17.10    Pfizer Inc.
        17.10.1    Financial Analysis
        17.10.2    Product Portfolio
        17.10.3    Demographic Reach and Achievements
        17.10.4    Mergers and Acquisitions
        17.10.5    Certifications
18    Global Topical Pain Relief Market - Distribution Model (Additional Insight)
    18.1    Overview 
    18.2    Potential Distributors 
    18.3    Key Parameters for Distribution Partner Assessment 
19    Key Opinion Leaders (KOL) Insights (Additional Insight)
20    Company Competitiveness Analysis (Additional Insight)

    20.1    Very Small Companies
    20.2    Small Companies
    20.3    Mid-Sized Companies
    20.4    Large Companies
    20.5    Very Large Companies
21    Payment Methods (Additional Insight)
    21.1    Government Funded
    21.2    Private Insurance
    21.3    Out-of-Pocket

 

*Additional insights provided are customisable as per client requirements.

Key Questions Answered in the Report

In 2023, the global market for topical pain relief attained a value of USD 10.61 billion.

The market is anticipated to grow at a CAGR of 5% during the forecast period of 2024-2032 to reach a value of USD 16.45 billion by 2032.

The major drivers of the market include the rising prevalence of arthritis and other bone-related diseases, rising pharmaceutical industry, and growing geriatric population.

The increasing investments in the healthcare and pharmaceutical industries is the key industry trend propelling the growth of the market.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The major classes of the product in the market are opioids and non-opioids.

The leading product types in the industry are over-the-counter and prescription.

The significant formulations of the product in the market are ointment, gel, spray, and patch, among others.

The major distribution channels of the product in the industry are online, pharmacies and drug stores, and retail and grocery stores, among others.

The major players in the industry are Sanofi SA, Novartis AG, GlaxoSmithKline Plc., Reckitt Benckiser Group Plc., and Johnson & Johnson Consumer Inc., among others.

Purchase Full Report

Mini Report

$ 3499     $2999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 5999     $5499
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 8299     $7499
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 10499     $9499
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER